According to IVERIC bio's latest financial reports the company has a price-to-book ratio of 11.6.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 5.37 | 0.43% |
2021-12-31 | 5.35 | 64.46% |
2020-12-31 | 3.25 | -10.52% |
2019-12-31 | 3.63 | 806.55% |
2018-12-31 | 0.4008 | -86.44% |
2017-12-31 | 2.96 | -262.2% |
2016-12-31 | -1.82 | -103.95% |
2015-12-31 | 46.1 | 344.71% |
2014-12-31 | 10.4 | 73.16% |
2013-12-31 | 5.99 | |
2012-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.86 | -75.21% | ๐บ๐ธ USA |